🔬 Third-party verified peptides · Free Express Post over $200 CAD
Pantheon Peptides
Fat Loss4 cited studies

Pancragen

KEDW pancreatic bioregulator peptide studied for glucose metabolism and endocrine pancreatic function.

Also known as: KEDW peptide
SummaryMechanismDosingSafetyStudies
Research use only — not for human consumption.

What it is

Pancragen (KEDW; Lys-Glu-Asp-Trp) is a short peptide bioregulator associated with pancreatic function, insulin and C-peptide dynamics, glucose metabolism, and age-related metabolic research.

Mechanism of action

Pancragen is studied for tissue-specific regulation of pancreatic cell function and differentiation during aging, including endocrine pancreatic markers and glucose-metabolism support.

Evidence summary

Evidence includes old-monkey endocrine-function work, elderly type 2 diabetes reports, and peptide bioregulator differentiation studies. Treat as educational research support rather than a replacement for diabetes care.

Pantheon dosing guide

Application
Subcutaneous injection.
BAC Water
2 mL
Dose
500 mcg-1 mg (5-10 units)
Frequency & Cycle Length
Daily for 10-20 days. Repeat 1-3 times yearly as needed.
Timing
Morning, ideally before food.
Key Benefits
Supports pancreatic function. Supports healthy glucose metabolism. Supports insulin and C-peptide signaling. Promotes metabolic balance.

Additional research protocol context

The printed guide above is Pantheon's dosing reference. These broader research examples are provided as context and may use different schedules.

  • 20 mg vial reconstituted with 2.0 mL bacteriostatic water
  • 500 mcg-1 mg subcutaneous daily
  • 10-20 day courses; morning before food is most common

Side effects

  • Injection-site redness, tenderness, itching, or mild swelling
  • Headache, nausea, lightheadedness, or digestive changes
  • Customers using glucose-lowering medications should consult a clinician before use

Cited studies

  1. Goncharova ND, et al. (2015). Impact of tetrapeptide Pancragen on endocrine function of the pancreas in old monkeys. PubMed.
    PMID 25946840Read source ↗
  2. Korkushko OV, et al. (2010). Efficacy of Pancragen peptide in elderly patients with type 2 diabetes mellitus. Problems of Endocrine Pathology.
    Read source ↗
  3. Khavinson V, et al. (2012). Peptides tissue-specifically stimulate cell differentiation during aging. PubMed.
    PMID 22808515Read source ↗
  4. Khavinson V, et al. (2013). Effects of Pancragen on differentiation of pancreatic cells during ageing. PubMed.
    PMID 23486591Read source ↗
Disclaimer

Content is provided for research and educational purposes only. Products are intended solely for laboratory research and are not for human use. Nothing on this page constitutes medical advice.